{
    "symbol": "LCI",
    "quarter": 2,
    "year": 2022,
    "date": "2022-02-03 20:52:05",
    "content": " For fiscal 2022, we now expect net sales in the range of $335 million to $360 million, down from $370 million to $400 million; adjusted gross margin as a percentage of net sales of approximately 14% to 15%, down from approximately 19% to 21%; adjusted R&D expense in the range of $23 million to $26 million, down from $25 million to $28 million; adjusted SG&A expense ranging from $55 million to $58 million, unchanged; adjusted interest expense of approximately $52 million, unchanged; the full year adjusted effective tax rate in the range of 23% to 24%, up from 22% to 23%; adjusted EBITDA in the range of $0 to $8 million, down from $22 million to $32 million; and lastly, capital expenditures to be approximately $10 million to $14 million, unchanged."
}